CFM Wealth Partners LLC Sells 97 Shares of HCA Healthcare, Inc. (NYSE:HCA)

CFM Wealth Partners LLC lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 4.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,931 shares of the company’s stock after selling 97 shares during the quarter. CFM Wealth Partners LLC’s holdings in HCA Healthcare were worth $580,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. U.S. Capital Wealth Advisors LLC grew its stake in shares of HCA Healthcare by 11.5% during the fourth quarter. U.S. Capital Wealth Advisors LLC now owns 2,951 shares of the company’s stock valued at $886,000 after purchasing an additional 305 shares during the last quarter. Greenleaf Trust raised its holdings in HCA Healthcare by 0.8% in the fourth quarter. Greenleaf Trust now owns 5,771 shares of the company’s stock worth $1,732,000 after purchasing an additional 46 shares during the period. Spire Wealth Management raised its holdings in shares of HCA Healthcare by 23.0% during the fourth quarter. Spire Wealth Management now owns 9,913 shares of the company’s stock worth $2,975,000 after acquiring an additional 1,851 shares during the period. DAVENPORT & Co LLC raised its holdings in shares of HCA Healthcare by 1.9% during the fourth quarter. DAVENPORT & Co LLC now owns 11,333 shares of the company’s stock worth $3,402,000 after acquiring an additional 214 shares during the period. Finally, Deroy & Devereaux Private Investment Counsel Inc. increased its stake in HCA Healthcare by 1.6% in the 4th quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 120,812 shares of the company’s stock valued at $36,262,000 after buying an additional 1,931 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

NYSE HCA opened at $330.24 on Monday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The company has a market capitalization of $83.65 billion, a PE ratio of 15.03, a price-to-earnings-growth ratio of 1.13 and a beta of 1.64. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a 50-day simple moving average of $313.33 and a 200 day simple moving average of $353.29.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the company earned $5.90 earnings per share. On average, research analysts predict that HCA Healthcare, Inc. will post 24.89 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.87%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s payout ratio is presently 12.02%.

Analysts Set New Price Targets

HCA has been the topic of several recent research reports. Truist Financial lowered their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. KeyCorp cut their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. TD Cowen reduced their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Finally, Bank of America reduced their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $385.67.

Insider Transactions at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This represents a 6.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.70% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.